To what Extent does Vitamin D and its Serum Levels Influence the Severity of Hidradenitis Suppurativa: A Literature Review
DOI:
https://doi.org/10.2340/actadv.v104.40321Keywords:
hidradenitis suppurativa, acne inversa, diet therapy, vitamin DAbstract
Vitamin D plays a role in inflammatory skin conditions and can improve them. Hidradenitis suppurativa (HS) is an autoinflammatory chronic skin disease in which most patients exhibit a hypovitaminosis D. However, it is uncertain whether vitamin D supplementation could relieve the severity of HS. A systematic literature search of PubMed and Web of Science was conducted on 4 September 2023. Studies that investigated vitamin D and its potential implications for the severity of HS were included. In contrast, studies that focused on the prevalence of vitamin D deficiency were excluded, as well as studies on syndromic HS. Seven studies with a total of 575 patients were included in the qualitative synthesis, of which 3 utilized a cross-sectional design, 2 were pilot studies, 1 a controlled cohort study, and 1 a prospective case-control study. In all included studies, HS patients were vitamin D deficient. There was evidence indicating that serum vitamin D levels negatively correlated with the severity of the disease, and at least suggestive evidence that vitamin D supplementation could have a positive impact on the course of HS. To better understand these correlations, conducting a randomized controlled trial study on vitamin D and its effects on HS severity is imperative.
Downloads
References
Zouboulis CC, Benhadou F, Byrd AS, Chandran NS, Giamarellos-Bourboulis EJ, Fabbrocini G, et al. What causes hidradenitis suppurativa? - 15 years after. Exp Dermatol 2020; 29: 1154-1170.
https://doi.org/10.1111/exd.14214 DOI: https://doi.org/10.1111/exd.14214
Sabat R, Jemec GBE, Matusiak L, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers 2020; 6: 18.
https://doi.org/10.1038/s41572-020-0149-1 DOI: https://doi.org/10.1038/s41572-020-0149-1
Wolk K, Join-Lambert O, Sabat R. Aetiology and pathogenesis of hidradenitis suppurativa. Br J Dermatol 2020; 183: 999-1010.
https://doi.org/10.1111/bjd.19556 DOI: https://doi.org/10.1111/bjd.19556
Martorell A, Garcia-Martinez FJ, Jimenez-Gallo D, Pascual JC, Pereyra-Rodriguez J, Salgado L, et al. An update on hidradenitis suppurativa (part i): epidemiology, clinical aspects, and definition of disease severity. Actas Dermosifiliogr 2015; 106: 703-715. DOI: https://doi.org/10.1016/j.adengl.2015.09.008
https://doi.org/10.1016/j.ad.2015.06.004 DOI: https://doi.org/10.1016/j.ad.2015.06.004
Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 2020; 82: 1045-1058.
https://doi.org/10.1016/j.jaad.2019.08.090 DOI: https://doi.org/10.1016/j.jaad.2019.08.090
Hessam S, Sand M, Gambichler T, Skrygan M, Ruddel I, Bechara FG. Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop. Br J Dermatol 2018; 178: 761-767.
https://doi.org/10.1111/bjd.16019 DOI: https://doi.org/10.1111/bjd.16019
Lima AL, Karl I, Giner T, Poppe H, Schmidt M, Presser D, et al. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol 2016; 174: 514-521.
https://doi.org/10.1111/bjd.14214 DOI: https://doi.org/10.1111/bjd.14214
Schlapbach C, Hanni T, Yawalkar N, Hunger RE. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol 2011; 65: 790-798.
https://doi.org/10.1016/j.jaad.2010.07.010 DOI: https://doi.org/10.1016/j.jaad.2010.07.010
Agamia NF, Sorror OA, Sayed NM, Ghazala RA, Echy SM, Moussa DH, et al. Overexpression of hypoxia-inducible factor-1alpha in hidradenitis suppurativa: the link between deviated immunity and metabolism. Arch Dermatol Res 2023; 315: 2107-2118.
https://doi.org/10.1007/s00403-023-02594-6 DOI: https://doi.org/10.1007/s00403-023-02594-6
Gulliver W, Zouboulis CC, Prens E, Jemec GB, Tzellos T. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord 2016; 17: 343-351.
https://doi.org/10.1007/s11154-016-9328-5 DOI: https://doi.org/10.1007/s11154-016-9328-5
Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015; 29: 619-644.
https://doi.org/10.1111/jdv.12966 DOI: https://doi.org/10.1111/jdv.12966
Hendricks AJ, Hsiao JL, Lowes MA, Shi VY. A comparison of international management guidelines for hidradenitis suppurativa. Dermatology 2021; 237: 81-96.
https://doi.org/10.1159/000503605 DOI: https://doi.org/10.1159/000503605
Kechichian E, Ezzedine K. Vitamin D and the skin: an update for dermatologists. Am J Clin Dermatol 2018; 19: 223-235.
https://doi.org/10.1007/s40257-017-0323-8 DOI: https://doi.org/10.1007/s40257-017-0323-8
Passeron T, Bouillon R, Callender V, Cestari T, Diepgen TL, Green AC, et al. Sunscreen photoprotection and vitamin D status. Br J Dermatol 2019; 181: 916-931.
https://doi.org/10.1111/bjd.17992 DOI: https://doi.org/10.1111/bjd.17992
Brandao L, Moura R, Tricarico PM, Gratton R, Genovese G, Moltrasio C, et al. Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole exome sequencing approach. J Dermatol Sci 2020; 99: 17-22.
https://doi.org/10.1016/j.jdermsci.2020.05.004 DOI: https://doi.org/10.1016/j.jdermsci.2020.05.004
Weber I, Giefer J, Martin KL. Effects of exercise and dietary modifications on hidradenitis suppurativa: a systematic review. Am J Clin Dermatol 2023; 24: 343-357.
https://doi.org/10.1007/s40257-023-00756-w DOI: https://doi.org/10.1007/s40257-023-00756-w
Kelly G, Sweeney CM, Fitzgerald R, O'Keane MP, Kilbane M, Lally A, et al. Vitamin D status in hidradenitis suppurativa. Br J Dermatol 2014; 170: 1379-1380.
https://doi.org/10.1111/bjd.12900 DOI: https://doi.org/10.1111/bjd.12900
Lee JW, Heo YW, Lee JH, Lee S. Epidemiology and comorbidity of hidradenitis suppurativa in Korea for 17 years: a nationwide population-based cohort study. J Dermatol 2023; 50: 778-786.
https://doi.org/10.1111/1346-8138.16747 DOI: https://doi.org/10.1111/1346-8138.16747
Kirsten N, Mohr N, Augustin M, Hilbring C, Girbig G, Neumann F, et al. Abstract 106: vitamin D and its correlation with the BMI and the MEDAS-Score in patients with hidradenitis suppurativa: results of a monocentric cross-sectional study. J Dtsch Dermatol Ges 2021; 19: 53.
Seetan K, Eldos B, Saraireh M, Omari R, Rubbai Y, Jayyusi A, et al. Prevalence of low vitamin D levels in patients with hidradenitis suppurativa in Jordan: a comparative cross-sectional study. PLoS One 2022; 17: e0265672.
https://doi.org/10.1371/journal.pone.0265672 DOI: https://doi.org/10.1371/journal.pone.0265672
Navarro I, Gonzalez-Lopez MA, Sierra I, Olmos JM, Blanco R, Hernandez JL. Bone metabolism in patients with hidradenitis suppurativa: a case-control study. Acta Derm Venereol 2022; 102: adv00825.
https://doi.org/10.2340/actadv.v102.3504 DOI: https://doi.org/10.2340/actadv.v102.3504
Sanchez-Diaz M, Salvador-Rodriguez L, Montero-Vilchez T, Martinez-Lopez A, Arias-Santiago S, Molina-Leyva A. Cumulative inflammation and HbA1c levels correlate with increased intima-media thickness in patients with severe hidradenitis suppurativa. J Clin Med 2021; 10: 5222.
https://doi.org/10.3390/jcm10225222 DOI: https://doi.org/10.3390/jcm10225222
Moltrasio C, Tricarico PM, Genovese G, Gratton R, Marzano AV, Crovella S. 25-Hydroxyvitamin D serum levels inversely correlate to disease severity and serum C-reactive protein levels in patients with hidradenitis suppurativa. J Dermatol 2021; 48: 715-717.
https://doi.org/10.1111/1346-8138.15797 DOI: https://doi.org/10.1111/1346-8138.15797
Fabbrocini G, Marasca C, Luciano MA, Guarino M, Poggi S, Fontanella G, et al. Vitamin D deficiency and hidradenitis suppurativa: the impact on clinical severity and therapeutic responsivity. J Dermatolog Treat 2021; 32: 843-844.
https://doi.org/10.1080/09546634.2020.1714538 DOI: https://doi.org/10.1080/09546634.2020.1714538
Ricceri F, Pescitelli L, Di Cesare A, Rosi E, Prignano F. 053 OS11-02 - oral session: serum vitamin D in hidradenitis suppurativa patients: a pilot study. Exp Dermatol 2019; 28: 28.
Guillet A, Brocard A, Bach Ngohou K, Graveline N, Leloup AG, Ali D, et al. Verneuil's disease, innate immunity and vitamin D: a pilot study. J Eur Acad Dermatol Venereol 2015; 29: 1347-1353.
https://doi.org/10.1111/jdv.12857 DOI: https://doi.org/10.1111/jdv.12857
Olmos JM, Hernandez JL, Garcia-Velasco P, Martinez J, Llorca J, Gonzalez-Macias J. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults. Osteoporos Int 2016; 27: 105-113.
https://doi.org/10.1007/s00198-015-3219-6 DOI: https://doi.org/10.1007/s00198-015-3219-6
Martinez J, Olmos JM, Hernandez JL, Pinedo G, Llorca J, Obregon E, et al. Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study. Clin Chim Acta 2009; 409: 70-74.
https://doi.org/10.1016/j.cca.2009.08.020 DOI: https://doi.org/10.1016/j.cca.2009.08.020
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930.
https://doi.org/10.1210/jc.2011-0385 DOI: https://doi.org/10.1210/jc.2011-0385
Lim SK, Ha JM, Lee YH, Lee Y, Seo YJ, Kim CD, et al. Comparison of vitamin D levels in patients with and without acne: a case-control study combined with a randomized controlled. Trial PLoS One 2016; 11: e0161162.
https://doi.org/10.1371/journal.pone.0161162 DOI: https://doi.org/10.1371/journal.pone.0161162
Barrea L, Savanelli MC, Di Somma C, Napolitano M, Megna M, Colao A, et al. Vitamin D and its role in psoriasis: an overview of the dermatologist and nutritionist. Rev Endocr Metab Disord 2017; 18: 195-205.
https://doi.org/10.1007/s11154-017-9411-6 DOI: https://doi.org/10.1007/s11154-017-9411-6
Bergler-Czop B, Brzezinska-Wcislo L. Serum vitamin D level: the effect on the clinical course of psoriasis. Postepy Dermatol Alergol 2016; 33: 445-449.
https://doi.org/10.5114/ada.2016.63883 DOI: https://doi.org/10.5114/ada.2016.63883
Afzal S, Brondum-Jacobsen P, Bojesen SE, Nordestgaard BG. Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 2014; 2: 298-306.
https://doi.org/10.1016/S2213-8587(13)70200-6 DOI: https://doi.org/10.1016/S2213-8587(13)70200-6
Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 2015; 16: 341-349.
https://doi.org/10.1111/obr.12239 DOI: https://doi.org/10.1111/obr.12239
Tzellos T, Zouboulis CC, Gulliver W, Cohen AD, Wolkenstein P, Jemec GB. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies. Br J Dermatol 2015; 173: 1142-1155.
https://doi.org/10.1111/bjd.14024 DOI: https://doi.org/10.1111/bjd.14024
Waldron JL, Ashby HL, Cornes MP, Bechervaise J, Razavi C, Thomas OL, et al. Vitamin D: a negative acute phase reactant. J Clin Pathol 2013; 66: 620-622.
https://doi.org/10.1136/jclinpath-2012-201301 DOI: https://doi.org/10.1136/jclinpath-2012-201301
Lee WJ, Cha HW, Sohn MY, Lee SJ, Kim DW. Vitamin D increases expression of cathelicidin in cultured sebocytes. Arch Dermatol Res 2012; 304: 627-632.
https://doi.org/10.1007/s00403-012-1255-z DOI: https://doi.org/10.1007/s00403-012-1255-z
An JH, Cho DH, Lee GY, Kang MS, Kim SJ, Han SN. Effects of vitamin D supplementation on CD4+ T cell subsets and mTOR signaling pathway in high-fat-diet-induced obese mice. Nutrients 2021; 13: 796.
https://doi.org/10.3390/nu13030796 DOI: https://doi.org/10.3390/nu13030796
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews BMJ 2021; 372: n71.
https://doi.org/10.1136/bmj.n71 DOI: https://doi.org/10.1136/bmj.n71
Published
How to Cite
License
Copyright (c) 2024 Lea Lackner, Birgit-Christiane Zyriax, Brigitte Stephan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
